EFG ASSET MANAGEMENT (NORTH AMERICA) CORP. – Halozyme Therapeutics, Inc. Transaction History
EFG ASSET MANAGEMENT (NORTH AMERICA) CORP. portfolio value:
$5.96M
portfolio value
EFG ASSET MANAGEMENT (NORTH AMERICA) CORP. quarter portfolio value change:
-10.14%
quarter
Halozyme Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -12.34% | -21.21K shares | -1.60M | $39.54 | 150.75K |
| Q2 2022 | share | Decrease | -41.59% | -122.44K shares | -4.16M | $44 | 171.96K |
| Q1 2022 | share | Decrease | -0.42% | -1.24K shares | -153K | $39.88 | 294.41K |
| Q4 2021 | share | Increase | 0.00% | 295.65K shares | 11.89M | $40.32 | 295.65K |